Weaver C. Barksdale & Associates’s Hologic HOLX Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-286	Closed	-$11K	–	553
2015 Q4	$11K	Buy	286 +17	+6%	+$661	0.01%	240
2015 Q3	$11K	Sell	269 -39	-13%	-$1.55K	0.01%	241
2015 Q2	$12K	Sell	308 -29	-9%	-$1.01K	0.01%	237
2015 Q1	$11K	Sell	337 -63	-16%	-$1.93K	0.01%	262
2014 Q4	$11K	Sell	400 -49	-11%	-$1.26K	0.01%	242
2014 Q3	$11K	Buy	449 +23	+5%	+$581	0.01%	239
2014 Q2	$11K	Sell	426 -69	-14%	-$1.61K	0.01%	251
2014 Q1	$11K	Buy	495 +38	+8%	+$820	0.01%	238
2013 Q4	$10K	Hold	457	–	–	0.01%	267
2013 Q3	$9K	Buy	457 +28	+7%	+$596	0.01%	285
2013 Q2	$8K	Buy	+429	New	+$8.96K	0.01%	302

Other funds holding HOLX

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

TCM

Tran Capital Management San Rafael, California $869M AUM 52.91% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Weaver C. Barksdale & Associates's HOLX Position: Q1 2016 in Review

Weaver C. Barksdale & Associates sold out of Hologic (HOLX) in Q1 2016, closing a stake of 286 shares — an estimated $11K sold.

Weaver C. Barksdale & Associates first reported a position in HOLX in Q2 2013 and held it in 11 quarters. The position peaked at $12K in Q2 2015. 456 funds tracked by Wall St. Rank hold HOLX as of Q1 2016.

Weaver C. Barksdale & Associates reported no remaining Hologic position as of Q1 2016 after selling out during the quarter.
Weaver C. Barksdale & Associates sold 286 Hologic shares in Q1 2016, an estimated $11K.
Weaver C. Barksdale & Associates first reported a position in Hologic in Q2 2013 and held it in 11 quarters.
Weaver C. Barksdale & Associates's Hologic position peaked at $12K in Q2 2015.
456 funds tracked by Wall St. Rank held Hologic as of Q1 2016.

Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2016, filed 5 Apr 2016.